<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet href="http://immunocompetent.com/styles/rss.css" type="text/css"?>
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
>
 <channel>
  <title>Immunocompetent</title>
  <link>http://immunocompetent.com/index.php?blogId=1</link>
  <description>&lt;p&gt;A prickly thorn in the side of America&#039;s confused influenza blogosphere.&lt;/p&gt;
</description>
  <pubDate>Sat, 05 Sep 2009 00:38:13 -0700</pubDate>
  <generator>http://www.lifetype.net</generator>
    <item>
   <title>Gene Squatters Claim the Next Pandemic</title>
   <description>
    &lt;p&gt;
If you think oil speculators are an ethically-challenged crowd, consider pandemic squatters.&amp;nbsp; There are many examples. For one of the ugliest and most audacious, we turn to Finland. 
&lt;/p&gt;
&lt;p&gt;
Finns are usually an inoffensive lot, but it seems that a few of their number are hoping for the big one to come.&amp;nbsp; A big pandemic, that is.&amp;nbsp; And they&#039;re putting their money on H5N2. Helsinki-based Remedal, a tiny company with no apparent independent R&amp;amp;D capacity, &lt;a href=&quot;http://www.wipo.int/pctdb/en/fetch.jsp?LANG=ENG&amp;amp;DBSELECT=PCT&amp;amp;SERVER_TYPE=19-10&amp;amp;SORT=41244938-KEY&amp;amp;TYPE_FIELD=256&amp;amp;IDB=0&amp;amp;IDOC=377157&amp;amp;C=10&amp;amp;ELEMENT_SET=FILENAME&amp;amp;RESULT=10&amp;amp;TOTAL=17&amp;amp;START=1&amp;amp;DISP=25&amp;amp;FORM=SEP-0/HITNUM,B-ENG,DP,MC,AN,PA,ABSUM-ENG&amp;amp;SEARCH_IA=FI2006000402&amp;amp;QUERY=%28FP%2fH5N1%29+&quot; target=&quot;_blank&quot;&gt;has filed for patent on basically all injected or intranasal human vaccines containing an H5 and an N2 antigen&lt;/a&gt; (i.e. against H5N1 recombined with &#039;normal&#039; human H3N2). 
&lt;/p&gt;
&lt;p&gt;
For good measure, Remedal further specifically claims such a vaccine using three HA genes that are WHO GISN materials: A/Hong Kong/213/2003, A/Vietnam/1194/2004, and A/Vietnam/1203/2004.
&lt;/p&gt;
&lt;p&gt;
So, Remedal hopes, if an H5N2 recombinant goes pandemic (or seriously threatens to), it will own rights to the vaccine - and make a fortune. Some might vainly hope that we can have confidence that the patent authorities weed out this kind of application, but that would be an unfounded hope, because &lt;a href=&quot;http://query.nytimes.com/gst/fullpage.html?res=9403EFDC103DF933A15750C0A9679C8B63&quot; target=&quot;_blank&quot;&gt;lousy patent applications issue all the time&lt;/a&gt;.
&lt;/p&gt;
&lt;p&gt;
It&#039;s clear that the company has no ability to develop and market a flu vaccine. It&#039;s only announced compound is a &amp;quot;dietary supplement&amp;quot; that it says aids alcohol metabolism, reducing hangovers and liver damage. Even there it is looking for somebody to buy and commercialize the compound. Remedal of Helsinki is not about to provide the world with pandemic flu vaccine, although it is ready to claim a royalty on every shot if its gamble on H5N2 pans out. (And probably file a patent infringement lawsuit against anyone selling an H5N2 vaccine, driving up the price for everyone.) Worse than Roche and Tamiflu.&amp;nbsp; At least Roche makes &lt;em&gt;something&lt;/em&gt;. (No comment here on the perverse incentives to crime that issuing such patents might generate.) 
&lt;/p&gt;
&lt;p&gt;
Part of what&#039;s going on with this kind of patent squatting is an intellectual property system in dire need of reform, which goes well-beyond the H5N1 issue. But WHO&#039;s blind eye cast on pandemic influenza vaccine patents is a big problem too.&amp;nbsp; When pressed to acknowledge intellectual property issues at all, WHO usually apologizes for whatever is the &lt;em&gt;status quo. &lt;/em&gt;Its stockpile effort to date is a good example. WHO should be out there drawing a public health line around claims on pandemic vaccines and, in particular, patent claims on WHO GISN materials. If that were the case, then the GISN&#039;s crisis wouldn&#039;t be nearly as severe, and attempts at unethical pandemic squatting would be reduced.&amp;nbsp;
&lt;/p&gt;
&lt;p&gt;
&amp;nbsp; 
&lt;/p&gt;
   </description>
   <link>http://immunocompetent.com/index.php?op=ViewArticle&amp;articleId=12&amp;blogId=1</link>
   <comments>http://immunocompetent.com/index.php?op=ViewArticle&amp;articleId=12&amp;blogId=1</comments>
   <guid>http://immunocompetent.com/index.php?op=ViewArticle&amp;articleId=12&amp;blogId=1</guid>
      <dc:creator>perezoso</dc:creator>
      
    <category>Capitalists</category>
      
    <category>WHO Secretariat</category>
      
    <category>Patents</category>
      
    <category>Vaccines</category>
      
    <category>Stockpiles</category>
      
    <category>Fearmongers</category>
      
    <category>GISN</category>
         <pubDate>Tue, 19 Aug 2008 13:15:46 -0500</pubDate>
   <source url="http://immunocompetent.com/rss.php?blogId=1&amp;profile=rss20">Immunocompetent</source>
     </item>
    <item>
   <title>Richard Holbrooke and Laurie Garrett are Full of Sh*t</title>
   <description>
    &lt;p&gt;
&amp;nbsp;&lt;em&gt;Update: 6 September 2008&lt;/em&gt;
&lt;/p&gt;
&lt;p&gt;
&lt;strong&gt;An Important Note About This Blog Entry &lt;/strong&gt;
&lt;/p&gt;
&lt;p&gt;
The short essay below was originally written as a Letter to the Editor of the &lt;em&gt;Washington Post&lt;/em&gt;, because I believed that it was very important to publicly correct the numerous errors and misperceptions contained in the Holbrooke / Garrett editorial.
&lt;/p&gt;
&lt;p&gt;
When the &lt;em&gt;Washington Post&lt;/em&gt; did not publish the letter, I sent it to a number people and urgently asked them if they would be so kind as to put forward the ideas contained in the letter, given the important international humanitarian interest in reforming the GISN.
&lt;/p&gt;
&lt;p&gt;
I was therefore very grateful when Ambassador Wibisono of Indonesia adapted the essay below and was able to have it published in the &lt;em&gt;Jakarta Post&lt;/em&gt; on my behalf. An utmost priority in the debate over influenza virus sharing is widely circulating the powerful arguments for changing the current system, therefore, I again thank Ambassador Wibisono for his willingness to carry this message to a broader public.
&lt;/p&gt;
&lt;p&gt;
EH
&lt;/p&gt;
&lt;p&gt;
------ 
&lt;/p&gt;
&lt;p&gt;
... and it&#039;s time for America to wake up to that fact.
&lt;/p&gt;
&lt;p&gt;
In their badly informed &lt;em&gt;Washington Post&lt;/em&gt; op-ed &lt;a href=&quot;http://www.washingtonpost.com/wp-dyn/content/article/2008/08/08/AR2008080802919.html?nav=rss_print/outlook&quot; target=&quot;_blank&quot;&gt;&amp;quot;&#039;Sovereignty&#039; That Risks Global Health&amp;quot;&lt;/a&gt;
(10 August), Richard Holbrooke and Laurie Garrett make a number of
factual mistakes and misleading statements, some of which I will
enumerate here.
&lt;/p&gt;
&lt;p&gt;

The existing World Health Organization (WHO) system of
sharing influenza viruses, called the Global Influenza Surveillance
Network, is radically unjust in that it takes resources from developing
countries and provides little in return, and leaves us all more
vulnerable to an influenza pandemic. Indonesia and other countries that
have taken the initiative to reform the WHO system are taking a
laudable and overdue step to improve public health for all.
&lt;br /&gt;
&lt;br /&gt;
There is no constituency seeking to create &amp;quot;viral sovereignty&amp;quot;. &lt;em&gt;De
facto&lt;/em&gt;, such sovereignty already exists in international law.
Inexplicably, the authors mislead by simply ignoring that fact and, in
particular, 20 years of development of the &lt;a href=&quot;http://www.cbd.int&quot; target=&quot;_blank&quot;&gt;Convention on Biological
Diversity&lt;/a&gt; which, among other international instruments, recognizes
national sovereignty over genetic resources, including microbes.
Viruses are, unequivocally, genetic resources subject to national
sovereignty, whether Holbrooke and Garrett want to admit it or not.
&lt;br /&gt;
&lt;/p&gt;
&lt;p&gt;
Holbrooke and Garrett claim that it is &amp;quot;ludicrous&amp;quot; to apply
sovereignty to genetic resources that easily cross borders. Their
position belies ignorance of both biodiversity and related law and
policy. As any farmer, biologist, or duck hunter can tell you, most
genetic resources cross borders: birds, plants, insects, microbes,
crops, and practically everything else made of DNA (or, as in the case
of flu, RNA). This simple biological truth has not stopped sovereignty
or international cooperation in biodiversity use and protection.
Transboundary biodiversity issues have been discussed and addressed for
over two decades by the UN. Holbrooke and Garrett have no apparently
clue about this, otherwise they would not have made such an off-base
assertion.
&lt;br /&gt;
&lt;br /&gt;
They further state that &amp;quot;&lt;em&gt;The WHO has elicited pledges from the
world&#039;s major drug companies not to exploit international repositories
of genetic data for commercial benefit&lt;/em&gt;&amp;quot;. Such pledges, even if they
existed in the form claimed, are contradicted by fact. First of all, a
number of companies have lodged US and international patent claims over
hundreds of H5N1 genetic sequences - resources that were freely given
to WHO by Indonesia and other countries. These resources come from the
gene repositories.
&lt;br /&gt;
&lt;br /&gt;
Secondly, major pharmaceutical companies have &lt;a href=&quot;http://www.clinicaltrials.gov/ct2/results?term=H5N1&quot; target=&quot;_blank&quot;&gt;advanced clinical
trials underway utilizing Indonesian, Vietnamese, and other viruses in
vaccines&lt;/a&gt;. One vaccine using a Vietnamese strain is licensed. The
companies intend to profit from sales of these vaccines, and Indonesia
(and other countries) will receive nothing of the proceeds. The fact of
the matter is that industry - large and small - massively benefits from
resources of the WHO system, and no commeasurate benefit accrues to
Indonesia and other countries who, ironically, are facing the gravest
immediate threat from H5N1.
&lt;br /&gt;
&lt;br /&gt;
Further, contrary to Holbrooke and Garrett&#039;s erroneous suggestion,
&lt;a href=&quot;http://www.who.int/csr/ihr/en/&quot; target=&quot;_blank&quot;&gt;the revised International Health Regulations do not require viruses to
be sent to WHO&lt;/a&gt;, and Indonesia has not defied them. The revised
regulations mandate sharing of information on disease outbreaks of
international importance, and such information continues to be shared.&amp;nbsp;
The authors further - and unaccountably - allege that Indonesia has
violated &amp;quot;a host of other WHO agreements&amp;quot;. What agreements? I have
participated in the WHO negotiations on influenza virus sharing, where
I have not seen either Holbrooke or Garrett, and I am unaware of any
such allegations.
&lt;/p&gt;
&lt;p&gt;
In reality, Indonesia has repeatedly offered to provide more
viruses to WHO. Neither Indonesia, nor its Health Minister, are
intrinsically opposed to providing viruses. Rather, the stumbling block
is an unwillingness of some countries to implement a just Material
Transfer Agreement (MTA) to define the rights of parties when viruses
are transferred.
&lt;br /&gt;
&lt;br /&gt;
The underlying proposition that Garrett and Holbrooke rail against
in their callous editorial is that Indonesia and other countries are
asking for a reasonable MTA for influenza viruses - one that doesn&#039;t
rob them - and for an unbiased WHO.&amp;nbsp; The hypocrisy of the US and some
other countries is especially palpable when one looks at the typical
agreements signed by US institutions for transfer of viruses between
themselves. Those agreements are far more restrictive than anything
that Indonesia or its allies have proposed for sharing their viruses.
&lt;br /&gt;
&lt;br /&gt;
The move to reform the WHO Global Influenza Surveillance Network is neither
self-destructive nor anti-Western. Holbrooke and Garrett&#039;s lashing
out against Indonesia is uninformed about the pertinent policy and law
related to genes and sovereignty, and callous toward the concerns of
developing countries trying to better protect their own citizens from a
pandemic. In their blindness to the obvious injustices of the WHO
system, Garrett and Holbrooke recklessly dismiss a very important, and
potentially very positive - but delicate - negotiation underway to make
the multilateral system more fair and equitable.
&lt;br /&gt;
&lt;br /&gt;
It&#039;s time for the US and its allies to stop hurling abuse at
Indonesia and to acknowledge the need to reform the virus sharing
system so that developing countries receive tangible benefits for their
participation. Indonesia and other developing countries have put
concrete and detailed proposals on the table for negotiation in Geneva.
The real danger to public health is not sovereignty that is already a
reality; but that these proposals are not discussed and implemented,
leaving us with a dysfunctional global influenza surveillance system.
&lt;br /&gt;
&lt;br /&gt;
&lt;/p&gt;
   </description>
   <link>http://immunocompetent.com/index.php?op=ViewArticle&amp;articleId=8&amp;blogId=1</link>
   <comments>http://immunocompetent.com/index.php?op=ViewArticle&amp;articleId=8&amp;blogId=1</comments>
   <guid>http://immunocompetent.com/index.php?op=ViewArticle&amp;articleId=8&amp;blogId=1</guid>
      <dc:creator>perezoso</dc:creator>
      
    <category>WHO PIP IGM</category>
      
    <category>Fearmongers</category>
      
    <category>Indonesia</category>
      
    <category>MTAs</category>
         <pubDate>Tue, 12 Aug 2008 21:17:46 -0500</pubDate>
   <source url="http://immunocompetent.com/rss.php?blogId=1&amp;profile=rss20">Immunocompetent</source>
     </item>
   </channel>
</rss>